What researchers mean by LL-37
LL-37 is the C-terminal peptide of human cathelicidin (hCAP18), researched for antimicrobial and immunomodulatory properties in laboratory systems. It is not a casual wellness supplement.
Research peptide · For research purposes only
Healing, recovery & inflammation research
Educational research guide only. To compare companies that offer LL-37, open the Products page — scores belong to sellers, not this compound as a whole.
Healing, recovery & inflammation research
LL-37 is a human cathelicidin-derived antimicrobial peptide studied in host-defense and inflammation research. For research purposes only.
Also known as: CAP-18 · Cathelicidin LL-37 · hCAP18 fragment
LL-37 is the C-terminal peptide of human cathelicidin (hCAP18), researched for antimicrobial and immunomodulatory properties in laboratory systems. It is not a casual wellness supplement.
Research handling requires care; sellers should avoid infection-treatment marketing.
LL-37 is a research peptide — not an approved antibiotic replacement. Research purposes only.
Companies on PurityWatch may list LL-37 as a compound they offer for research. Listing a compound does not mean it is approved for human use.
Primarily host-defense, antimicrobial, and inflammation-related laboratory models — not as consumer medical advice.